» Articles » PMID: 33729090

Transmembrane Domains of Type III-secreted Proteins Affect Bacterial-host Interactions in Enteropathogenic

Overview
Journal Virulence
Specialty Microbiology
Date 2021 Mar 17
PMID 33729090
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Many bacterial pathogens utilize a specialized secretion system, termed type III secretion system (T3SS), to translocate effector proteins into host cells and establish bacterial infection. The T3SS is anchored within the bacterial membranes and contains a long needle/filament that extends toward the host-cell and forms, at its distal end, a pore complex within the host membrane. The T3SS pore complex consists of two bacterial proteins, termed SctB and SctE, which have conflicting targeting indications; a signal sequence that targets to secretion to the extracellular environment via the T3SS, and transmembrane domains (TMDs) that target to membrane localization. In this study, we investigate whether the TMD sequences of SctB and SctE have special features that differentiate them from classical TMDs and allow them to escape bacterial membrane integration. For this purpose, we exchanged the SctB and SctE native TMDs for alternative hydrophobic sequences and found that the TMD sequences of SctB and SctE dictate membrane destination (bacterial versus host membrane). Moreover, we examined the role of the SctB TMD sequence in the activity of the full-length protein, post secretion, and found that the TMD does not serve only as a hydrophobic segment, but is also involved in the ability of the protein to translocate itself and other proteins into and across the host cell membrane.

Citing Articles

The sequence of events of enteropathogenic . 's type III secretion system translocon assembly.

Gershberg J, Morhaim M, Rostrovsky I, Eichler J, Sal-Man N iScience. 2024; 27(3):109108.

PMID: 38375228 PMC: 10875159. DOI: 10.1016/j.isci.2024.109108.


The transmembrane domains of the type III secretion system effector Tir are involved in its secretion and cellular activities.

Braverman D, Gershberg J, Sal-Man N Front Cell Infect Microbiol. 2023; 13:1103552.

PMID: 36864885 PMC: 9971567. DOI: 10.3389/fcimb.2023.1103552.


Recent insights into type-3 secretion system injectisome structure and mechanism of human enteric pathogens.

Chen P, Goldberg M Curr Opin Microbiol. 2022; 71:102232.

PMID: 36368294 PMC: 10510281. DOI: 10.1016/j.mib.2022.102232.

References
1.
Diepold A, Wagner S . Assembly of the bacterial type III secretion machinery. FEMS Microbiol Rev. 2014; 38(4):802-22. DOI: 10.1111/1574-6976.12061. View

2.
Gaytan M, Martinez-Santos V, Soto E, Gonzalez-Pedrajo B . Type Three Secretion System in Attaching and Effacing Pathogens. Front Cell Infect Microbiol. 2016; 6:129. PMC: 5073101. DOI: 10.3389/fcimb.2016.00129. View

3.
Krampen L, Malmsheimer S, Grin I, Trunk T, Luhrmann A, Gier J . Revealing the mechanisms of membrane protein export by virulence-associated bacterial secretion systems. Nat Commun. 2018; 9(1):3467. PMC: 6110835. DOI: 10.1038/s41467-018-05969-w. View

4.
Deng W, Puente J, Gruenheid S, Li Y, Vallance B, Vazquez A . Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A. 2004; 101(10):3597-602. PMC: 373508. DOI: 10.1073/pnas.0400326101. View

5.
Wachter C, Beinke C, Mattes M, Schmidt M . Insertion of EspD into epithelial target cell membranes by infecting enteropathogenic Escherichia coli. Mol Microbiol. 1999; 31(6):1695-707. DOI: 10.1046/j.1365-2958.1999.01303.x. View